Atossa Therapeutics, Inc. ATOS
Set alert
2.28 USD -0.02 -1.09%
As of Nov 3, 10:34 AM ET
2.28 Day range 2.35
1.70 52-week range 14.85
- YTD
- -74.29%
- 1 year
- -82.36%
- Open
- 2.35
- Prev close
- 2.30
- Mkt cap
- 22.70M
- Vol
- 7.33K
- Avg vol
- 71.46K
- EPS
- -4.45
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.28
- High
- 2.35
- Forward P/E
- -3.81
- Beta
- 1.23
- Short ratio
- 14.73
- Inst. own
- 28.16%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.31
- 200-d avg
- 1.39
- 1y target
- 6.00
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 6.00 +163.7% upside
Now 2.28
- Target (low)
- 4.00
- Target (mean)
- 6.00
- Target (high)
- 7.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy2
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.06 | -0.07 – -0.05 | -0.06 | 0.0% | 0 | 0.0% | 4 |
| Next quarter | -0.06 | -0.06 – -0.06 | -0.05 | -20.0% | 0 | 0.0% | 1 |
| Current year | -0.2125 | -0.22 – -0.20 | -0.24 | +11.5% | 0 | 0.0% | 4 |
| Next year | -0.25 | -0.29 – -0.20 | -0.2125 | -17.6% | 0 | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 9, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Nov 13, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 5, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 31, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 11, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Aug 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 28, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 20, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Jun 6, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| May 14, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| May 13, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 2, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 12, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Sep 8, 2023 | Cantor Fitzgerald | Initiated | — | Overweight |
| Sep 17, 2020 | Ascendiant Capital | Initiated | — | Buy |
| Dec 18, 2019 | Maxim Group | Upgrade | Hold | Buy |
| Jan 26, 2018 | Maxim Group | Initiated | — | Buy |
| Oct 7, 2013 | Sidoti & Co. | Downgrade | Buy | Neutral |
| Apr 15, 2013 | Sidoti & Co. | Initiated | — | Buy |
| Mar 20, 2013 | Dawson James | Downgrade | Market Outperform | Buy |